Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol …
H Kojima, K Yoshihara, T Sawada, H Kondo… - European Journal of …, 2008 - Elsevier
The purpose of this study was to evaluate the feasibility of using a counter polymer in
polyethylene oxide (PEO)/polyethylene glycol (PEG) polymeric matrices for the sustained …
polyethylene oxide (PEO)/polyethylene glycol (PEG) polymeric matrices for the sustained …
Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles
SM Wong, IW Kellaway, S Murdan - International Journal of Pharmaceutics, 2006 - Elsevier
The slow dissolution rate exhibited by poorly water-soluble drugs is a major challenge in the
drug development process. Following oral administration, drugs with slow dissolution rates …
drug development process. Following oral administration, drugs with slow dissolution rates …
Supersaturated controlled release matrix using amorphous dispersions of glipizide
Spray dried dispersions (SDDs) of glipizide, a BCS Class II model drug, were prepared
using various grades of hydroxypropyl methylcellulose acetate succinate (HPMCAS) and …
using various grades of hydroxypropyl methylcellulose acetate succinate (HPMCAS) and …
[PDF][PDF] Impact of hydrophilic polymer solubilization on bioavailability enhancement of repaglinide by solid dispersion
M El-Nabarawi, I Khalil, R Saad - Inven Rapid Pharm Tech, 2016 - researchgate.net
Repaglinide (RPG) is poorly water soluble drug BCS (Low solubility, High permeability). The
objective of this study was to enhance the dissolution of RPG for oral drug delivery. RPG …
objective of this study was to enhance the dissolution of RPG for oral drug delivery. RPG …
Comparative studies of the effects of novel excipients amino acids with cyclodextrins on enhancement of dissolution and oral bioavailability of the non-ionizable drug …
Despite significant innovations in pharmaceutical industries, low water solubility is still a
common biopharmaceutics-related problem that encounters 40% of marketed …
common biopharmaceutics-related problem that encounters 40% of marketed …
Optimization for glimepiride dissolution enhancement utilizing different carriers and techniques
RR Makar, R Latif, EA Hosni… - Journal of Pharmaceutical …, 2013 - Springer
The present work is a comparative study that matches between carriers and techniques
used to prepare solid mixtures with glimepiride. The study is directed towards elucidation of …
used to prepare solid mixtures with glimepiride. The study is directed towards elucidation of …
Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions
T Zoeller, JB Dressman, S Klein - International journal of pharmaceutics, 2012 - Elsevier
Over the last decades the poor solubility of new drugs has become an important issue, with
one of the main challenges being to develop oral dosage forms with acceptable …
one of the main challenges being to develop oral dosage forms with acceptable …
Development and evaluation of solid dispersion based rapid disintegrating tablets of poorly water-soluble anti-diabetic drug
Glimepiride is an effective oral hypoglycemic agent that lowers the glucose level of blood by
stimulating insulin release from beta cells of the pancreas. However, the poor aqueous …
stimulating insulin release from beta cells of the pancreas. However, the poor aqueous …
Microencapsulation of an iron chelator for sustained release and crystal habit modification
S Venkataram, M Khohlokwane - Journal of microencapsulation, 1996 - Taylor & Francis
Abstract DMHP (1, 2-dimethyl-3-hydroxy-pyrid-4-one) is an orally-active iron chelator that
has a short biological half-life and hence: a sustained-release formulation is currently being …
has a short biological half-life and hence: a sustained-release formulation is currently being …
[HTML][HTML] Effect of raw material variability of glipizide on the in vitro dissolution rate and in vivo bioavailability performance: The importance of particle size
C Zhao, C Jin, H Gao, L Wang, H Liu, Z He - Asian journal of …, 2019 - Elsevier
The objective of this study was to understand the impact of active pharmaceutical
ingredients (API) particle size on a re-developed generic product of glipizide and to improve …
ingredients (API) particle size on a re-developed generic product of glipizide and to improve …